Q3 2016 Holdings
Filed 2016-11-14 | 142 holdings | $292.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $150.9M | 482,033 | 51.6% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $65.7M | 710,145 | 22.5% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $16.5M | 243,995 | 5.7% |
| CytomX Therapeutics, Inc.(CTMX) | Common | 23284F105 | $11.9M | 756,090 | 4.1% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $9.6M | 115,000 | 3.3% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $9.2M | 707,636 | 3.1% |
| Cellectis S.A.(CLLS) | Sponsored ADR | 15117K103 | $7.5M | 310,250 | 2.6% |
| Adaptimmune Theraputics plc(ADAPY) | Sponsored ADR | 00653A107 | $4.0M | 566,368 | 1.4% |
| BeiGene Ltd.(ONC) | Sponsored ADR | 07725L102 | $3.6M | 116,707 | 1.2% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $3.6M | 111,800 | 1.2% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $3.5M | 304,472 | 1.2% |
| Allscripts Healthcare Solutions, Inc.(MDRX) | Common | 01988P108 | $2.3M | 173,600 | 0.8% |
| Acadia Healthcare Company. Inc.(ACHC) | Common | 00404A109 | $1.7M | 35,200 | 0.6% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $210.5K | 2,660,131 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $155.1K | 1,484,089 | 0.1% |
| Allergan plc | Common | G0177J108 | $100.0K | 434,086 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $93.6K | 764,005 | 0.0% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $90.1K | 1,033,503 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $83.0K | 880,461 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $77.8K | 1,246,397 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $62.0K | 154,266 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $58.3K | 1,378,600 | 0.0% |
| Eli Lilly & Company(LLY) | Common | 532457108 | $57.3K | 713,767 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $53.8K | 623,030 | 0.0% |
| Amgen Inc.(AMGN) | Common | 031162100 | $53.7K | 321,640 | 0.0% |
| Unitedhealth Group, Inc.(UNH) | Common | 91324P102 | $46.4K | 331,100 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $44.9K | 231,413 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $44.8K | 246,560 | 0.0% |
| Mylan NV | Shares | N59465109 | $43.3K | 1,135,552 | 0.0% |
| Jazz Pharmaceuticals plc(JAZZ) | Shares | G50871105 | $40.3K | 331,411 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $39.8K | 337,312 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $38.8K | 1,146,689 | 0.0% |
| CVS Caremark Corporation(CVS) | Common | 126650100 | $36.7K | 411,891 | 0.0% |
| Teva Pharmaceutical Industries Limited(TEVA) | Sponsored ADR | 881624209 | $36.3K | 788,958 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $33.3K | 656,622 | 0.0% |
| Humana, Inc.(HUM) | Common | 444859102 | $29.2K | 164,800 | 0.0% |
| Alkermes plc(ALKS) | Shares | G01767105 | $27.4K | 581,944 | 0.0% |
| AmerisourceBergen Corporation(COR) | Common | 03073E105 | $26.7K | 330,687 | 0.0% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $23.5K | 402,541 | 0.0% |
| Agilent Technologies, Inc.(A) | Common | 00846U101 | $21.7K | 459,950 | 0.0% |
| The Medicines Company | Common | 584688105 | $21.3K | 564,438 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $19.6K | 248,800 | 0.0% |
| Endo International plc | Shares | G30401106 | $18.4K | 914,548 | 0.0% |
| Cepheid, Inc. | Common | 15670R107 | $17.6K | 333,590 | 0.0% |
| Puma Biotechnology, Inc.(PBYI) | Common | 74587V107 | $17.4K | 260,200 | 0.0% |
| Centene Corporation(CNC) | Common | 15135B101 | $17.2K | 256,500 | 0.0% |
| iShares Nasdaq Biotechnology ETF(IBB) | ETF | 464287556 | $16.7K | 57,670 | 0.0% |
| Universal Health Services, Inc.(UHS) | Class B | 913903100 | $16.6K | 134,680 | 0.0% |
| GlaxoSmithKline plc | Sponsored ADR | 37733W105 | $15.5K | 359,000 | 0.0% |
| AstraZeneca PLC(AZN) | Sponsored ADR | 046353108 | $15.2K | 463,800 | 0.0% |